1887

Abstract

Introduction. Vaccinia virus is the vaccine that was used to eradicate smallpox. This task was accomplished in 1977 and its completion certified in 1979 by the World Health Organization (WHO) ( Fenner , 1988 ). Since then poxvirus infections of humans have caused little disease and have been restricted to molluscum contagiosum and rare zoonoses such as cowpox (CPV), pseudocowpox, monkeypox, orf and yaba tumour viruses. Continued interest in vaccinia virus and other poxviruses has derived in part from the development of these viruses as cloning and expression vectors ( Mackett , 1982 Panicali & Paoletti, 1982 ) that have the potential as live vaccines to combat diseases other than smallpox (Panicali , 1983; Smith , 1983 1984 Paoletti , 1984 ).

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-9-1725
1993-09-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/9/JV0740091725.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-9-1725&mimeType=html&fmt=ahah

References

  1. Aguado B, Selmes IP, Smith GL. 1992; Nucleotide sequence of 21∙8 kbp of variola major virus strain Harvey and comparison with vaccinia virus.. Journal of General Virology 73:2887–2902
    [Google Scholar]
  2. Akkaraju GR, Whitaker-Dowling P, Youngner JS, Jagus R. 1989; Vaccinia specifie kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate.. Journal of Biological Chemistry 264:10321–10325
    [Google Scholar]
  3. Alcamí A, Smith GL. 1992; A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.. Cell 71:153–167
    [Google Scholar]
  4. Appleyard G, Andrews C. 1974; Neutralizing activities of antisera to poxvirus soluble antigens.. Journal of General Virology 23:197–200
    [Google Scholar]
  5. Appleyard G, Hapel AJ, Boulter EA. 1971; An antigenic difference between intracellular and extracellular rabbitpox virus.. Journal of General Virology 13:9–17
    [Google Scholar]
  6. Baroudy BM, Venkatesan S, Moss B. 1982; Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain.. Cell 28:315–324
    [Google Scholar]
  7. Bayliss CD, Condit RC. 1993; Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a resuit of aberrant late transcription.. Virology 194:254–262
    [Google Scholar]
  8. Beattie E, Tartaglia J, Paoletti E. 1991; Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon.. Virology 183:419–122
    [Google Scholar]
  9. Bennink JR, Yewdell JW, Smith GL, Moller C, Moss B. 1984; Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.. Nature, London 311:578–579
    [Google Scholar]
  10. Blackman KE, Bubel HC. 1972; Origin of the vaccinia virus hemagglutinin.. Journal of Virology 9:290–296
    [Google Scholar]
  11. Blasco R, Moss B. 1991; Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37 000-Dalton outer envelope protein.. Journal of Virology 65:5910–5920
    [Google Scholar]
  12. Blasco R, Moss B. 1992; Role of cell-associated enveloped vaccinia virus in cell-to-cell spread.. Journal of Virology 66:4170–4179
    [Google Scholar]
  13. Blasco R, Cole NB, Moss B. 1991; Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein.. Journal of Virology 65:4598–1608
    [Google Scholar]
  14. Blasco R, Sisler JR, Moss B. 1993; Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene.. Journal of Virology 67:3319–3325
    [Google Scholar]
  15. Blomquist MC, Hunt LT, Barker WC. 1984; Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors.. Proceedings of the National Academy of Sciences, U.S.A. 81:7363–7367
    [Google Scholar]
  16. Boone RF, Parr RP, Moss B. 1979; Intermolecular duplexes formed from polyadenylated vaccinia virus RNA. . Journal of Virology 30:365–374
    [Google Scholar]
  17. Boulter EA. 1969; Protection against poxviruses.. Proceedings of the Royal Society of Medicine 62:295–297
    [Google Scholar]
  18. Boulter EA, Appleyard G. 1973; Differences between extracellular and intracellular forms of poxviruses and their implications. Progress in Medical Virology 16:86–108
    [Google Scholar]
  19. Boursnell MEG, Foulds IJ, Campbell JI, Binns MM. 1988; Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen.. Journal of General Virology 69:2995–3003
    [Google Scholar]
  20. Brown CK, Turner PC, Moyer RW. 1991; Molecular characterization of the vaccinia virus hemagglutinin gene.. Journal of General Virology 65:3598–3606
    [Google Scholar]
  21. Brown F, Schild GC, Ada GL. 1986; Recombinant vaccinia viruses as vaccines.. Nature, London 319:549–550
    [Google Scholar]
  22. Brown JP, Twardzik DR, Marquardt H, Todaro GJ. 1985; Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor.. Nature, London 313:491–192
    [Google Scholar]
  23. Buller RML, Chakrabarti S, Cooper JA, Twardzik DR, Moss B. 1988a; Deletion of the vaccinia virus growth factor gene reduces virus virulence.. Journal of Virology 62:866–874
    [Google Scholar]
  24. Buller RML, Chakrabarti S, Moss B, Fredrickson T. 1988b; Cell proliferative response to vaccinia virus is mediated by VGF.. Virology 164:182–192
    [Google Scholar]
  25. Carrasco L, Bravo R. 1986; Specifie proteins synthesized during the viral lytic cycle in vaccinia virus-infected HeLa cells: analysis by high-resolution, two-dimensional gel electrophoresis.. Journal of Virology 58:569–577
    [Google Scholar]
  26. Carrasco L, Esteban M. 1982; Modification of membrane permeability in vaccinia virus-infected cells.. Virology 117:62–69
    [Google Scholar]
  27. Chang HW, Watson JC, Jacobs BL. 1992; The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.. Proceedings of the National Academy of Sciences, U.S.A. 89:4825–4829
    [Google Scholar]
  28. Chang W, Lim JG, Hellstrom I, Gentry LE. 1988; Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum.. Journal of Virology 62:1080–1083
    [Google Scholar]
  29. Child SJ, Franke CA, Hruby DE. 1988; Inhibition of vaccinia virus replication by nicotinamide: evidence for ADP-ribosylation of viral proteins.. Virus Research 9:119–132
    [Google Scholar]
  30. Chua TP, Smith CE, Reith RW, Williamson JD. 1990; Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues.. Immunology 69:202–208
    [Google Scholar]
  31. Cohrs RJ, Condit RC, Pacha RF, Thompson CL, Sharma OK. 1989; Modulation of ppp(A2∥p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus. . Journal of Virology 63:948–951
    [Google Scholar]
  32. Collier LH. 1955; The development of a stable smallpox vaccine.. Journal of Hygiene 53:76–101
    [Google Scholar]
  33. Condit RC, Motyczka A. 1981; Isolation and preliminary characterization of temperature-sensitive mutants of vaccinia virus.. Virology 113:224–241
    [Google Scholar]
  34. Coupar BEH, Andrew ME, Both GW, Boyle DB. 1986; Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.. European Journal of Immunology 16:1479–1487
    [Google Scholar]
  35. Dales S, Pogo BGT. 1981; Biology of poxviruses.. Virology Monographs 18:1–101
    [Google Scholar]
  36. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. 1984; The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.. Nature, London 312:763–767
    [Google Scholar]
  37. Davies MV, Chang HW, Jacobs BL, Kaufman RJ. 1993; The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms.. Journal of Virology 67:1688–1692
    [Google Scholar]
  38. Davies MV, Elroy-Stein O, Jagus R, Moss B, Kaufman RJ. 1992; The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.. Journal of Virology 66:1945–1950
    [Google Scholar]
  39. Doms RW, Blumenthal R, Moss B. 1990; Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.. Journal of Virology 64:4884–4892
    [Google Scholar]
  40. Duncan SA, Smith GL. 1992; Identification and character-ization of an extracellular envelope glycoprotein afifecting vaccinia virus egress.. Journal of Virology 66:1610–1621
    [Google Scholar]
  41. Engelstad M, Smith GL. 1993; The vaccinia virus 42 kDa envelope protein is required for envelopment and egress of extracellular virus and for virulence.. Virology 194:627–637
    [Google Scholar]
  42. Engelstad M, Howard ST, Smith GL. 1992; A constitutively expressed vaccinia virus gene encodes a 42 kDa glycoprotein related to complement control factors that forms part of the extracellular envelope.. Virology 188:801–810
    [Google Scholar]
  43. Eppstein DA, Marsh YV, Schreiber AB, Newman SR, Todaro GJ, Nestor JJ. 1985; Epidermal growth factor receptor occupancy inhibits vaccinia virus infection.. Nature, London 318:663–665
    [Google Scholar]
  44. Essani K, Dales S. 1979; Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.. Virology 95:385–394
    [Google Scholar]
  45. Fenner F, Anderson DA, Arita I, Jezek Z, Ladnyi ID. 1988 Smallpox and its eradication. Geneva: World Health Organization;
    [Google Scholar]
  46. Fenner F, Witter R, Dumbell KR. 1989 The Orthopox-viruses London: Academie Press;
    [Google Scholar]
  47. Flexner C, Hugin R, Moss B. 1987; Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.. Nature, Ixtndon 330:259–262
    [Google Scholar]
  48. Garon CF, Moss B. 1971; Glycoprotein synthesis in cells infected with vaccinia virus. II. A glycoprotein component of the virion.. Virology 46:233–246
    [Google Scholar]
  49. Garon CF, Barbosa E, Moss B. 1978; Visualization of an inverted terminal repetition in vaccinia virus DNA.. Proceedings of the National Academy of Sciences, U.S.A. 75:4863–4867
    [Google Scholar]
  50. Geshelin P, Berns KI. 1974; Characterization and localization of the naturally occurring cross-links in vaccinia virus DNA.. Journal of Molecular Biology 88:785–796
    [Google Scholar]
  51. Goebel SJ, Johnson GP, Perkus ME, Davis SW, Winslow JP, Paoletti E. 1990; The complete DNA sequence of vaccinia virus.. Virology 179:247–266
    [Google Scholar]
  52. Gordon J, Kovala T, Dales S. 1988; Molecular characterization of a prominent antigen of the vaccinia virus envelope.. Virology 167:361–369
    [Google Scholar]
  53. Hirt P, Hiller G, Witter R. 1986; Localization and fine structure of a vaccinia virus gene encoding an envelope antigen.. Journal of Virology 58:757–764
    [Google Scholar]
  54. Holowczak JA. 1970; Glycopeptides of vaccinia virus. I. Pre-liminary characterization and hexosamine content.. Virology 42:87–99
    [Google Scholar]
  55. Howard ST, Chan YS, Smith GL. 1991; Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumour necrosis factor receptor family.. Virology 180:633–647
    [Google Scholar]
  56. Ichihashi Y, Dales S. 1971; Biogenesis of poxviruses: inter-relationship between hemagglutinin production and polykaryo-cytosis.. Virology 46:533–543
    [Google Scholar]
  57. Isaacs SN, Kotwal GJ, Moss B. 1992a; Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence.. Proceedings of the National Academy of Sciences, U.S.A. 89:628–632
    [Google Scholar]
  58. Isaacs SN, Wolffe EJ, Payne LG, Moss B. 1992b; Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.. Journal of Virology 66:7217–7224
    [Google Scholar]
  59. Jin D, Li Z, Jin Q, Yuwen H, Hou Y. 1989; Vaccinia virus hemagglutinin. A novel member of the immunoglobulin superfamily.. Journal of Experimental Medicine 170:571–576
    [Google Scholar]
  60. King CS, Cooper JA, Moss B, Twardzik DR. 1986; Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.. Molecular and Cellular Biology 6:332–336
    [Google Scholar]
  61. Koonin EV, Senrevich TG. 1992; Vaccinia virus encodes four putative DNA and/or RNA helicases distantly related to each other.. Journal of General Virology 73:989–993
    [Google Scholar]
  62. Kotwal GJ, Moss B. 1988; Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins.. Nature, London 335:176–178
    [Google Scholar]
  63. Kotwal GJ, Moss B. 1989; Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily(published erratum appears in Journal of Virology 64, 966).. Journal of Virology 63:600–606
    [Google Scholar]
  64. Kotwal GJ, Hugin AW, Moss B. 1989; Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13800-Da secreted protein.. Virology 171:579–587
    [Google Scholar]
  65. Kotwal GJ, Isaacs SN, McKenzie R, Frank MM, Moss B. 1990; Inhibition of the complement cascade by the major secretory protein of vaccinia virus.. Science 250:827–830
    [Google Scholar]
  66. Lane JM, Ruben FL, Neff JM, Millar JD. 1969; Complications of smallpox vaccination, 1968. National surveillance in the United States.. New England Journal of Medicine 281:1201–1208
    [Google Scholar]
  67. Law KM, Smith GL. 1992; A vaccinia serine protease inhibitor which prevents virus-induced cell fusion.. Journal of General Virology 73:549–557
    [Google Scholar]
  68. Lin YZ, Ke XH, Tam JP. 1990; Growth inhibition by vaccinia virus growth factor.. Journal of Biological Chemistry 265:18884–18890
    [Google Scholar]
  69. Maa JS, Esteban M. 1987; Structural and functional studies of a 39000-Mr immunodominant protein of vaccinia virus.. Journal of Virology 61:3910–3919
    [Google Scholar]
  70. Maa JS, Rodriguez JF, Esteban M. 1990; Structural and functional characterization of a cell surface binding protein of vaccinia virus.. Journal of Biological Chemistry 265:1569–1577
    [Google Scholar]
  71. McCrae MA, Pennington TH. 1978; Specifie secretion of polypeptides from cells infected with vaccinia virus.. Journal of Virology 28:823–834
    [Google Scholar]
  72. Mackett M, Smith GL, Moss B. 1982; Vaccinia virus: a selectable eukaryotic cloning and expression vector.. Proceedings of the National Academy of Sciences, U.S.A. 79:7415–7419
    [Google Scholar]
  73. Mackett M, Smith GL, Moss B. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.. Journal of Virology 49:857–864
    [Google Scholar]
  74. McMahan CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Branan CI, Copeland NG, Huebner K, Croce CM, Cannizzarro LA, Benjamin D, Dower SK, Spriggs MK, Sims JE. 1991; A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.. EMBO Journal 10:2821–2832
    [Google Scholar]
  75. Mallon VR, Domber EA, Holowczak JA. 1985; Vaccinia virus proteins on the plasma membranes of infected cells. IL Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.. Virology 145:1–23
    [Google Scholar]
  76. Mendelsohn CL, Wimmer E, Racaniello VR. 1989; Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.. Cell 56:855–865
    [Google Scholar]
  77. Moore JB, Smith GL. 1992; Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.. EMBO Journal 11:1973–1980
    [Google Scholar]
  78. Morikawa S, Ueda Y. 1993; Characterization of vaccinia surface antigen expressed by recombinant baculovirus.. Virology 193:753–761
    [Google Scholar]
  79. Moss B. 1990; Regulation of vaccinia virus transcription.. Annual Review of Biochemistry 59:661–688
    [Google Scholar]
  80. Moss B, Rosenblum EN, Garon CF. 1971; Glycoprotein synthesis in cells infected with vaccinia virus. I. Non-virion glycoproteins.. Virology 46:221–232
    [Google Scholar]
  81. Moss B, Rosenblum EN, Garon CF. 1973; Glycoprotein synthesis in cells infected with vaccinia virus. 3. Purification and biosynthesis of the virion glycoprotein.. Virology 55:143–156
    [Google Scholar]
  82. Niles EG, Seto J. 1988; Vaccinia virus gene D8 encodes a virion transmembrane protein.. Journal of Virology 62:3772–3778
    [Google Scholar]
  83. Pacha RF, Meis RJ, Condit RC. 1990; Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA.. Journal of Virology 64:3853–3863
    [Google Scholar]
  84. Paez E, Esteban M. 1984a; Nature and mode of action of vaccinia virus products that block activation of the interferon-mediated ppp(A2∥p)nA-synthetase.. Virology 134:29–39
    [Google Scholar]
  85. Paez E, Esteban M. 1984b; Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon System.. Virology 134:12–28
    [Google Scholar]
  86. Paez E, Esteban M. 1985; Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.. Journal of Virology 56:75–84
    [Google Scholar]
  87. Palumbo GJ, Buller RML. 1991; Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication.. Virology 180:457–463
    [Google Scholar]
  88. Palumbo GJ, Pickup DJ, Fredrickson TN, McIntyre LJ, Buller RML. 1989; Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus.. Virology 172:262–273
    [Google Scholar]
  89. Palumbo GJ, Glasgow WC, Buller RML. 1993; Poxvirus-induced alteration of arachidonate metabolism.. Pro-ceedings of the National Academy of Sciences, U.S.A. 90:2020–2024
    [Google Scholar]
  90. Panicali D, Paoletti E. 1982; Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.. Proceedings of the National Academy of Sciences, U.S.A. 79:4927–4931
    [Google Scholar]
  91. Panicali D, Davis SW, Weinberg RL, Paoletti E. 1983; Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin.. Proceedings of the National Academy of Sciences, U.S.A. 80:5364–5368
    [Google Scholar]
  92. Paoletti E, Lipinskas BR, Samsanoff C, Mercer S, Panicali D. 1984; Construction of live vaccinia viruses using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.. Proceedings of the National Academy of Sciences, U.S.A. 81:193–197
    [Google Scholar]
  93. Patel AH, Gafeney DF, Subak-Sharpe JH, Stow ND. 1990; DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister.. Journal of General Virology 71:2013–2021
    [Google Scholar]
  94. Payne LG. 1978; Polypeptide composition of extracellular enveloped vaccinia virus.. Journal of General Virology 27:28–37
    [Google Scholar]
  95. Payne LG. 1979; Identification of the vaccinia hemagglutinin polypeptide from a cell System yielding large amounts of extracellular enveloped virus.. Journal of Virology 31:147–155
    [Google Scholar]
  96. Payne LG. 1980; Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia.. Journal of General Virology 50:89–100
    [Google Scholar]
  97. Payne LG. 1992; Characterization of vaccinia virus glycoproteins by monoclonal antibody preparations.. Virology 187:251–260
    [Google Scholar]
  98. Payne LG, Kristensson K. 1979; Mechanism of vaccinia virus release and its specifie inhibition by N 1-isonicotinoyl-N 2-3-methyl-4-chlorobenzoylhydrazine.. Journal of Virology 32:614–622
    [Google Scholar]
  99. Payne LG, Kristensson K. 1985; Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo.. Journal of Virology 66:643–646
    [Google Scholar]
  100. Payne LG, Kristensson K. 1990; The polypeptide composition of vaccinia-infected cell membranes and rifampin bodies.. Virus Research 17:15–30
    [Google Scholar]
  101. Payne LG, Norrby E. 1978; Adsorption and penetration of enveloped and naked vaccinia virus particles.. Journal of Virology 27:19–27
    [Google Scholar]
  102. Perkus ME, Piccini A, Lipinskas BR, Paoletti E. 1985; Recombinant vaccinia virus: immunization against multiple pathogens.. Science 229:981–984
    [Google Scholar]
  103. Pickup DJ, Ink BS, Hu W, Ray CA, Joklik WK. 1986; Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases.. Proceedings of the National Academy of Sciences, U.S.A. 83:7698–7702
    [Google Scholar]
  104. Ray CA, Black RA, Kronheim SR, Greenstreet TA, Sleath PR, Salvensen GS, Pickup DJ. 1992; Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme.. Cell 69:597–604
    [Google Scholar]
  105. Reisner AH. 1985; Similarity between the vaccinia virus 19K early protein and epidermal growth factor.. Nature, London 313:801–803
    [Google Scholar]
  106. Rice AP, Kerr IM. 1984; Interferon-mediated, double-stranded RNA-dependent protein kinase is inhibited in extracts from vaccinia virus-infected cells.. Journal of Virology 50:229–236
    [Google Scholar]
  107. Rice AP, Roberts WK, Kerr IM. 1984; 2-5A accumulates to high levels in interferon-created, vaccinia virus-infected cells in the absence of any inhibition of virus replication.. Journal of Virology 50:220–228
    [Google Scholar]
  108. Rodriguez JF, Esteban M. 1987; Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein.. Journal of Virology 61:3550–3554
    [Google Scholar]
  109. Rodriguez JF, Smith GL. 1990; IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress.. Nucleic Acids Research 18:5347–5351
    [Google Scholar]
  110. Rodriguez JF, Paez E, Esteban M. 1987; A 14000-M r envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.. Journal of Virology 61:395–404
    [Google Scholar]
  111. Samuel CE. 1991; Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities.. Virology 183:1–11
    [Google Scholar]
  112. Sarov I, Joklik WK. 1972; Studies on the nature and location of the capsid polypeptides of vaccinia virions.. Virology 50:579–592
    [Google Scholar]
  113. Schmutz C, Payne LG, Gubser J, Witter R. 1991; A mutation in the gene encoding the vaccinia virus 37000-Mr protein confers resistance to an inhibitor of virus envelopment and release.. Journal of Virology 65:3435–3442
    [Google Scholar]
  114. Seki M, Oie M, Ichihashi Y, Shida FI. 1990; Flemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants.. Virology 175:372–384
    [Google Scholar]
  115. Shida H. 1986; Nucleotide sequence of the vaccinia virus hemagglutinin gene.. Virology 150:451–462
    [Google Scholar]
  116. Shida H, Dales S. 1981; Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecule.. Virology 111:56–72
    [Google Scholar]
  117. Shida H, Dales S. 1982; Biogenesis of vaccinia: molecular basis for the hemagglutinin-negative phenotype of the IHD-W strain.. Virology 117:219–237
    [Google Scholar]
  118. Shida H, Hinuma Y, Morita M, Kidokoro M, Suzuki K, Maruyama T, Takahashi-Nishimaki F, Sugimoto M, Kitamura R, Miyazawa T, Hayami M. 1988; Eflects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.. Journal of Virology 62:4474–4480
    [Google Scholar]
  119. Smith CA, Davis T, Wignall JM, Din WS, Farrah T, Upton C, McFadden G, Goodwin RG. 1991; T2 open reading frame from Shope fibroma virus encodes a soluble form of the TNF receptor.. Biochemical and Biophysical Research Communications. 176:335–342
    [Google Scholar]
  120. Smith GL, Chan YS. 1991; Two vaccinia virus proteins structurally related to interleukin-1 receptor and the immunoglobulin superfamily.. Journal of General Virology 72:511–518
    [Google Scholar]
  121. Smith GL, Mackett M, Moss B. 1983a; Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.. Nature, London 302:490–495
    [Google Scholar]
  122. Smith GL, Murphy BR, Moss B. 1983b; Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.. Proceedings of the National Academy of Sciences, U.S. A. 80:7155–7159
    [Google Scholar]
  123. Smith GL, Chan YS, Howard ST. 1991; Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat.. Journal of General Virology 72:1349–1376
    [Google Scholar]
  124. Smith GL, Godson NG, Nussenzweig V, Nussenzweig RS, Barnwell J, Moss B. 1984; Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus.. Science 224:397–399
    [Google Scholar]
  125. Smith GL, Howard ST, Chan YS. 1989; Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.. Journal of General Virology 70:2333–2343
    [Google Scholar]
  126. Sodeik B, Doms RW, Erisson M, Hiller G, Machamer CE, van’t Hof W, van Meer G, Moss B, Griffiths G. 1993; Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.. Journal of Cell Biology 121:521–541
    [Google Scholar]
  127. Spriggs M, Hruby DE, Maliszewski CR, Pickup DJ, Sims JE, Buller RML, Vanslyke J. 1992; Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein.. Cell 71:145–152
    [Google Scholar]
  128. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. 1989; A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.. Cell 56:849–853
    [Google Scholar]
  129. Stroobant P, Rice AP, Gullick WJ, Cheng DJ, Kerr IM, Waterfield MD. 1985; Purification and characterization of vaccinia virus growth factor.. Cell 42:383–393
    [Google Scholar]
  130. Takahashi-Nishimaki F, Funahashi SI, Miki K, Hashizume S, Sugimoto M. 1991; Regulation of plaque size and host range by a vaccinia virus gene related to complement System proteins.. Virology 181:158–164
    [Google Scholar]
  131. Thacore HR, Youngner JS. 1973a; Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. I. Rescue in cell cultures from different species.. Virology 56:505–511
    [Google Scholar]
  132. Thacore HR, Youngner JS. 1973b; Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.. Virology 56:512–522
    [Google Scholar]
  133. Tomley F, Binns M, Campbell J, Boursnell M. 1988; Sequence analysis of an 11∙2 kilobase, near-terminal BamHI fragment of fowlpox virus.. Journal of General Virology 69:1025–1040
    [Google Scholar]
  134. Townsend A, Bastin J, Gould K, Brownlee G, Andrew A, Boyle DB, Chan Y, Smith G. 1988; Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.. Journal of Experimental Medicine 168:1211–1224
    [Google Scholar]
  135. Traktman P. 1991; Molecular genetic and biochemical analysis of poxvirus DNA replication.. Seminars in Virology 2:291–304
    [Google Scholar]
  136. Turner GS, Squires EJ. 1971; Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus.. Journal of General Virology 13:19–25
    [Google Scholar]
  137. Turner PC, Moyer RW. 1992; An orthopoxvirus serpinlike gene Controls the ability of infected cells to fuse.. Journal of Virology 66:2076–2085
    [Google Scholar]
  138. Twardzik DR, Brown JP, Ranchalis JE, Todaro GJ, Moss B. 1985; Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors.. Proceedings of the National Academy of Sciences, U.S.A. 82:5300–5304
    [Google Scholar]
  139. Ueda Y, Ito M, Tagaya I. 1969; A specifie surface antigen induced by poxvirus.. Virology 38:180–182
    [Google Scholar]
  140. Ueda Y, Tagaya I, Amano H, Ito M. 1972; Studies on the early antigens induced by vaccinia virus.. Virology 49:794–800
    [Google Scholar]
  141. Ueda Y, Morikawa S, Matsuura Y. 1990; Identification and nucleotide sequence of the gene encoding a surface antigen induced by vaccinia virus.. Virology 177:588–594
    [Google Scholar]
  142. Upton C, Carrell RW, McFadden G. 1986; A novel member of the serpin superfamily is encoded on a circular plasmid-like DNA species isolated from rabbit cells.. FEBS Letters 207:115–120
    [Google Scholar]
  143. Upton C, Macen JL, Schreiber M, McFadden G. 1991; Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence.. Virology 184:370–382
    [Google Scholar]
  144. Upton C, Mossman K, McFadden G. 1992; Encoding of a homolog of IFN-γ receptor by myxoma virus.. Science 258:1369–1372
    [Google Scholar]
  145. Venkatesan S, Gershowitz A, Moss B. 1982; Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition.. Journal of Virology 44:637–646
    [Google Scholar]
  146. Watson JC, Chang HW, Jacobs BL. 1991; Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.. Virology 185:206–216
    [Google Scholar]
  147. Weintraub S, Dales S. 1974; Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane.. Virology 60:96–127
    [Google Scholar]
  148. Whitaker-Dowling P, Youngner JS. 1983; Vaccinia rescue of VSV from interferon-induced resistance: reversai of translation block and initiation of protein kinase activity.. Virology 13:128–136
    [Google Scholar]
  149. Whitaker-Dowling P, Youngner JS. 1984; Characterization of a specifie kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase.. Virology 137:171–181
    [Google Scholar]
  150. Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Kieny MP, Lathe R, Lecocq JP, Mackett M, Moss B, Koprowski H. 1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.. Proceedings of the National Academy of Sciences, U.S.A. 81:7194–7198
    [Google Scholar]
  151. Zhou J, Crawford L, McLean L, Sun XY, Stanley M, Almond N, Smith GL. 1990; Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.. Journal of General Virology 71:2185–2190
    [Google Scholar]
  152. Zhou J, Sun XY, Fernando GJP, Frazer IH. 1992; The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion.. Virology 189:678–686
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-9-1725
Loading
/content/journal/jgv/10.1099/0022-1317-74-9-1725
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error